RAD51C NM_058216.3(RAD51C):c.1026+5_1026+7del

CI-VAR-00020307Explore in graph →NM_058216.3:c.1026+5_1026+7delClinVar 128201 rs587781410

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
128201	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	2	Hereditary cancer-predisposing syndrome; Fanconi anemia complementation group O; Breast-ovarian cancer, familial, susceptibility to, 3; Hereditary site-specific ovarian cancer syndrome; Hereditary breast ovarian cancer syndrome; Breast and/or ovarian cancer; Uterine corpus cancer; Hereditary cancer; Inherited breast cancer and ovarian cancer; RAD51C-related cancer predisposition; Inherited ovarian cancer (without breast cancer); RAD51C-related disorder	germline	30	Mar 03, 2026	clinvar